The Weekly Roundup: Advocacy (9.28.18)

September 28, 2018 | Pamela Youngberg Dickson

Last week, the Senate passed the Patient Right to Know Drug Prices Act (S. 2554), swiftly followed by the House this week. The bill was designed to prevent gag clauses from limiting a pharmacist’s ability to tell patients if they will pay less out of pocket than with insurance. One of the bill’s authors, Senator Susan Collins (R-ME), says it is “counterintuitive” for prescriptions to be cheaper if paid with a debit card rather than an insurance card, and the bill has bipartisan support. Similar bills have been presented at the state level. In fact, check out some of the state-level advocacy tracking available here. It’s the result of one of many recent advocacy efforts in the pharmacy space, including a ban on retroactive DIR fees and pharmacy choice legislation that is currently stuck in committee and is likely to reemerge next session. Model PBM legislation is available here—and there’s plenty of time to reach out to your legislators in advance of next session. Are you a pharmacist interested in taking more direct action? Run for office

Continue reading →

Smart-Take: Prostate Cancer

September 21, 2018 | Pamela Youngberg Dickson

One in 9 men will be diagnosed with prostate cancer in his lifetime and it is the second most common cancer among men, behind only skin cancer. To help spread awareness of its risks and treatment, we've created another installation for our Smart-Take series—a downloadable page of health tips and information gathered on a range of topics that you can post in your stores.

Continue reading →